Prostate Cancer With ≤10 Bone Metastases Clinical Trials in Guangzhou, Guangdong

Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases